title: Assessment of liquid captopril formulations used in children.
authors.affiliation: Department of Pharmacy, University Hospitals of Leicester, Leicester, UK. hussain.mulla@uhl-tr.nhs.uk
authors.forename: H
authors.initials: H
authors.lastname: Mulla
authors.forename: N
authors.initials: N
authors.lastname: Hussain
authors.forename: S
authors.initials: S
authors.lastname: Tanna
authors.forename: G
authors.initials: G
authors.lastname: Lawson
authors.forename: B N
authors.initials: BN
authors.lastname: Manktelow
authors.forename: C
authors.initials: C
authors.lastname: Tuleu
authors.forename: N J
authors.initials: NJ
authors.lastname: Samani
authors.forename: H C
authors.initials: HC
authors.lastname: Pandya
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000097:blood / Q000737:chemistry*; D002216:Captopril / Q000097:blood / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D056687:Off-Label Use; D012996:Solutions; D013607:Tablets; D013810:Therapeutic Equivalency; D055815:Young Adult
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D012996:Solutions; D013607:Tablets; D002216:Captopril